{"transactions":[{"id":717998,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-07-02T20:07:30.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":168618,"source":{"system":"sec-edgar","filing":"0001104659-26-080320","document":"tm2619538-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465926080320/tm2619538-3_4seq1.xml","form_type":"4"}},{"id":719699,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-07-02T20:06:26.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":231618,"source":{"system":"sec-edgar","filing":"0001104659-26-080317","document":"tm2619538-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465926080317/tm2619538-2_4seq1.xml","form_type":"4"}},{"id":717645,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-07-02T20:05:16.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":168618,"source":{"system":"sec-edgar","filing":"0001104659-26-080309","document":"tm2619538-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465926080309/tm2619538-1_4seq1.xml","form_type":"4"}},{"id":723986,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-29T20:05:16.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":118618,"source":{"system":"sec-edgar","filing":"0001104659-26-078817","document":"tm2619089-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465926078817/tm2619089-3_4seq1.xml","form_type":"4"}},{"id":725879,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-26T20:20:50.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":181618,"source":{"system":"sec-edgar","filing":"0001104659-26-078286","document":"tm2619089-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465926078286/tm2619089-5_4seq1.xml","form_type":"4"}},{"id":725389,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-26T20:18:52.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":118618,"source":{"system":"sec-edgar","filing":"0001104659-26-078282","document":"tm2619089-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465926078282/tm2619089-4_4seq1.xml","form_type":"4"}},{"id":725411,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35123,"kind":"person","name":"Pearce Michael Cooper","position":1,"cik":"0001413616","reported_name":"Pearce Michael Cooper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-26T20:17:03.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":67173,"source":{"system":"sec-edgar","filing":"0001104659-26-078279","document":"tm2619089-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413616/000110465926078279/tm2619089-2_4seq1.xml","form_type":"4"}},{"id":725861,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-26T20:14:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":221146,"source":{"system":"sec-edgar","filing":"0001104659-26-078266","document":"tm2619089-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465926078266/tm2619089-1_4seq1.xml","form_type":"4"}},{"id":800688,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51297,"kind":"person","name":"Alloush Ramsey","position":1,"cik":"0002061883","reported_name":"Alloush Ramsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-24T21:29:55.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":62795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 22, 2026, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on April 22, 2027, 20,932 shares on April 22, 2028 and 20,931 shares on April 22, 2029."}],"balance_after":62795,"derivative":{"exercise_price":5.04,"expiration_date":"2036-04-22","underlying":"Common Stock, $0.0001 par value","underlying_shares":62795},"source":{"system":"sec-edgar","filing":"0001104659-26-048736","document":"tm2612721-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465926048736/tm2612721-3_4seq1.xml","form_type":"4"}},{"id":800687,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51297,"kind":"person","name":"Alloush Ramsey","position":1,"cik":"0002061883","reported_name":"Alloush Ramsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-04-24T21:29:55.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":46863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 22, 2026, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on April 22, 2027, 15,621 shares on April 22, 2028 and 15,621 shares on April 22, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":598543,"source":{"system":"sec-edgar","filing":"0001104659-26-048736","document":"tm2612721-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465926048736/tm2612721-3_4seq1.xml","form_type":"4"}},{"id":800690,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-24T21:28:53.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":41860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 22, 2026, the reporting person was granted 41,860 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 13,953 shares on April 22, 2027, 13,953 shares on April 22, 2028 and 13,954 shares on April 22, 2029."}],"balance_after":41860,"derivative":{"exercise_price":5.04,"expiration_date":"2036-04-22","underlying":"Common Stock, $0.0001 par value","underlying_shares":41860},"source":{"system":"sec-edgar","filing":"0001104659-26-048733","document":"tm2612721-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465926048733/tm2612721-2_4seq1.xml","form_type":"4"}},{"id":800689,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-04-24T21:28:53.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":28907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 22, 2026, the reporting person was granted 28,907 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 9,636 shares on April 22, 2027, 9,636 shares on April 22, 2028 and 9,635 shares on April 22, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":261371,"source":{"system":"sec-edgar","filing":"0001104659-26-048733","document":"tm2612721-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465926048733/tm2612721-2_4seq1.xml","form_type":"4"}},{"id":800685,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-24T21:27:06.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":82915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 22, 2026, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on April 22, 2027, 27,638 shares on April 22, 2028 and 27,639 shares on April 22, 2029."}],"balance_after":82915,"derivative":{"exercise_price":5.04,"expiration_date":"2036-04-22","underlying":"Common Stock, $0.0001 par value","underlying_shares":82915},"source":{"system":"sec-edgar","filing":"0001104659-26-048731","document":"tm2612721-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465926048731/tm2612721-1_4seq1.xml","form_type":"4"}},{"id":800684,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-04-24T21:27:06.000Z","date":"2026-04-22","kind":"grant","planned":false,"acquired":true,"shares":49277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 22, 2026, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on April 22, 2027, 16,426 shares on April 22, 2028 and 16,425 shares on April 22, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2435990,"source":{"system":"sec-edgar","filing":"0001104659-26-048731","document":"tm2612721-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465926048731/tm2612721-1_4seq1.xml","form_type":"4"}},{"id":1055250,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-27T01:54:28.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":false,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On October 19, 2015, the reporting person was granted 1,250,000 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that vested in accordance with the following schedule: 412,500 shares on January 7, 2016, 250,000 shares on September 22, 2016, 337,500 shares on January 7, 2017 and 250,000 shares on September 22, 2017. The 1,250,000 stock options are due to expire on October 19, 2025. Accordingly, the reporting person is exercising the stock options within the 60 days prior to the expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.065,"expiration_date":"2025-10-19","underlying":"Common Stock, $0.0001 par value","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001104659-25-083217","document":"tm2524441-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925083217/tm2524441-1_4seq1.xml","form_type":"4"}},{"id":1055249,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-27T01:54:28.000Z","date":"2025-08-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":10877,"price":7.47,"value":81251.19,"ownership":{"direct":true},"balance_after":2386713,"source":{"system":"sec-edgar","filing":"0001104659-25-083217","document":"tm2524441-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925083217/tm2524441-1_4seq1.xml","form_type":"4"}},{"id":1055248,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-27T01:54:28.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":true,"shares":1250000,"price":0.065,"value":81250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Due to administrative error, the number of non-derivative securities beneficially owned by the reporting person was incorrectly reported as 2,397,590 instead of 1,147,590 on a Form 4 filed on June 20, 2025. This column reflects the corrected balance, as effected by the transactions reported on this Form 4."}],"balance_after":2397590,"source":{"system":"sec-edgar","filing":"0001104659-25-083217","document":"tm2524441-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925083217/tm2524441-1_4seq1.xml","form_type":"4"}},{"id":1072637,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:18:06.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,667 shares on August 5, 2028, 16,667 shares on August 5, 2029 and 16,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":211146,"source":{"system":"sec-edgar","filing":"0001104659-25-075272","document":"tm2522819-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925075272/tm2522819-5_4seq1.xml","form_type":"4"}},{"id":1072657,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:17:19.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":171618,"source":{"system":"sec-edgar","filing":"0001104659-25-075270","document":"tm2522819-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465925075270/tm2522819-4_4seq1.xml","form_type":"4"}},{"id":1072219,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:16:13.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":108618,"source":{"system":"sec-edgar","filing":"0001104659-25-075266","document":"tm2522819-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465925075266/tm2522819-3_4seq1.xml","form_type":"4"}},{"id":1072148,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35123,"kind":"person","name":"Pearce Michael Cooper","position":1,"cik":"0001413616","reported_name":"Pearce Michael Cooper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:15:40.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":57173,"source":{"system":"sec-edgar","filing":"0001104659-25-075263","document":"tm2522819-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413616/000110465925075263/tm2522819-2_4seq1.xml","form_type":"4"}},{"id":1072128,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:14:23.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":108618,"source":{"system":"sec-edgar","filing":"0001104659-25-075260","document":"tm2522819-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925075260/tm2522819-1_4seq1.xml","form_type":"4"}},{"id":1091276,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:50:54.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":88618,"source":{"system":"sec-edgar","filing":"0001104659-25-066240","document":"tm2520050-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465925066240/tm2520050-5_4seq1.xml","form_type":"4"}},{"id":1091529,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:50:05.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":161146,"source":{"system":"sec-edgar","filing":"0001104659-25-066239","document":"tm2520050-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925066239/tm2520050-4_4seq1.xml","form_type":"4"}},{"id":1091219,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35123,"kind":"person","name":"Pearce Michael Cooper","position":1,"cik":"0001413616","reported_name":"Pearce Michael Cooper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:48:55.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":37173,"source":{"system":"sec-edgar","filing":"0001104659-25-066238","document":"tm2520050-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413616/000110465925066238/tm2520050-3_4seq1.xml","form_type":"4"}},{"id":1091558,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:47:36.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":151618,"source":{"system":"sec-edgar","filing":"0001104659-25-066237","document":"tm2520050-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465925066237/tm2520050-2_4seq1.xml","form_type":"4"}},{"id":1091211,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:46:22.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":88618,"source":{"system":"sec-edgar","filing":"0001104659-25-066236","document":"tm2520050-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925066236/tm2520050-1_4seq1.xml","form_type":"4"}},{"id":1104517,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51297,"kind":"person","name":"Alloush Ramsey","position":1,"cik":"0002061883","reported_name":"Alloush Ramsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:06:47.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":62795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 17, 2025, the reporting person was granted 62,795 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 20,932 shares on January 1, 2026, 20,932 shares on January 1, 2027 and 20,931 shares on January 1, 2028."}],"balance_after":62795,"derivative":{"exercise_price":6.31,"expiration_date":"2035-06-17","underlying":"Common Stock, $0.0001 par value","underlying_shares":62795},"source":{"system":"sec-edgar","filing":"0001104659-25-061156","document":"tm2518547-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925061156/tm2518547-3_4seq1.xml","form_type":"4"}},{"id":1104516,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51297,"kind":"person","name":"Alloush Ramsey","position":1,"cik":"0002061883","reported_name":"Alloush Ramsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-20T20:06:47.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":46863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2025, the reporting person was granted 46,863 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 15,621 shares on January 1, 2026, 15,621 shares on January 1, 2027 and 15,621 shares on January 1, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":551680,"source":{"system":"sec-edgar","filing":"0001104659-25-061156","document":"tm2518547-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925061156/tm2518547-3_4seq1.xml","form_type":"4"}},{"id":1104515,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:06:01.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":41860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 17, 2025, the reporting person was granted 41,860 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 13,953 shares on January 1, 2026, 13,953 shares on January 1, 2027 and 13,954 shares on January 1, 2028."}],"balance_after":41860,"derivative":{"exercise_price":6.31,"expiration_date":"2035-06-17","underlying":"Common Stock, $0.0001 par value","underlying_shares":41860},"source":{"system":"sec-edgar","filing":"0001104659-25-061155","document":"tm2518547-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925061155/tm2518547-2_4seq1.xml","form_type":"4"}},{"id":1104514,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-20T20:06:01.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":28907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2025, the reporting person was granted 28,907 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 9,636 shares on January 1, 2026, 9,636 shares on January 1, 2027 and 9,635 shares on January 1, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":232464,"source":{"system":"sec-edgar","filing":"0001104659-25-061155","document":"tm2518547-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925061155/tm2518547-2_4seq1.xml","form_type":"4"}},{"id":1104513,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:05:13.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":82915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 17, 2025, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on January 1, 2026, 27,638 shares on January 1, 2027 and 27,639 shares on January 1, 2028."}],"balance_after":82915,"derivative":{"exercise_price":6.31,"expiration_date":"2035-06-17","underlying":"Common Stock, $0.0001 par value","underlying_shares":82915},"source":{"system":"sec-edgar","filing":"0001104659-25-061149","document":"tm2518547-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925061149/tm2518547-1_4seq1.xml","form_type":"4"}},{"id":1104512,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-06-20T20:05:13.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":49277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2025, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on January 1, 2026, 16,426 shares on January 1, 2027 and 16,425 shares on January 1, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2397590,"source":{"system":"sec-edgar","filing":"0001104659-25-061149","document":"tm2518547-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925061149/tm2518547-1_4seq1.xml","form_type":"4"}},{"id":1158457,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-05T21:34:52.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":4834,"price":6.84,"value":33064.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 4,834 of the underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 2, 2025, was $6.73 to $7.05. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2348313,"source":{"system":"sec-edgar","filing":"0001104659-25-044612","document":"tm2514029-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925044612/tm2514029-3_4seq1.xml","form_type":"4"}},{"id":1158458,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-05T21:34:22.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":2409,"price":6.84,"value":16477.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 2,409 of the underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 2, 2025, was $6.73 to $7.05. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":203557,"source":{"system":"sec-edgar","filing":"0001104659-25-044611","document":"tm2514029-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925044611/tm2514029-2_4seq1.xml","form_type":"4"}},{"id":1158456,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51297,"kind":"person","name":"Alloush Ramsey","position":1,"cik":"0002061883","reported_name":"Alloush Ramsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-05-05T21:31:11.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":2857,"price":6.84,"value":19541.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 2,857 of the underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 2, 2025, was $6.73 to $7.05. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":504817,"source":{"system":"sec-edgar","filing":"0001104659-25-044606","document":"tm2514029-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925044606/tm2514029-1_4seq1.xml","form_type":"4"}},{"id":1170743,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-04-16T23:07:59.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2024, the reporting person was granted 175,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 58,333 shares on May 1, 2025, 58,333 shares on May 1, 2026 and 58,334 shares on May 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods. Due to administrative error, the above transactions are being reported late. The aggregate amount of securities beneficially owned includes the delinquent transactions plus all transactions reported in Form 4s filed after the date of the delinquent transactions."}],"balance_after":2353147,"source":{"system":"sec-edgar","filing":"0001104659-25-035599","document":"tm2512519-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925035599/tm2512519-2_4seq1.xml","form_type":"4"}},{"id":1170742,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-04-16T23:07:59.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 3, 2024, the reporting person was granted 175,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that vested or will vest in accordance with the following schedule: 58,333 shares on July 3, 2024, 58,333 shares on July 3, 2025 and 58,334 shares on July 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods. Due to administrative error, the above transactions are being reported late. The aggregate amount of securities beneficially owned includes the delinquent transactions plus all transactions reported in Form 4s filed after the date of the delinquent transactions."}],"balance_after":2178147,"source":{"system":"sec-edgar","filing":"0001104659-25-035599","document":"tm2512519-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925035599/tm2512519-2_4seq1.xml","form_type":"4"}},{"id":1170741,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-04-16T23:06:23.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On May 1, 2024, the reporting person was granted 80,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 26,666 shares on May 1, 2025, 26,667 shares on May 1, 2026 and 26,667 shares on May 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods. Due to administrative error, the above transactions are being reported late. The aggregate amount of securities beneficially owned includes the delinquent transactions plus all transactions reported in Form 4s filed after the date of the delinquent transactions."}],"balance_after":205966,"source":{"system":"sec-edgar","filing":"0001104659-25-035598","document":"tm2512519-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925035598/tm2512519-1_4seq1.xml","form_type":"4"}},{"id":1170740,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-04-16T23:06:23.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 3, 2024, the reporting person was granted 80,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that vested or will vest in accordance with the following schedule: 26,666 shares on July 3, 2024, 26,667 shares on July 3, 2025 and 26,667 shares on July 3, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods. Due to administrative error, the above transactions are being reported late. The aggregate amount of securities beneficially owned includes the delinquent transactions plus all transactions reported in Form 4s filed after the date of the delinquent transactions."}],"balance_after":125966,"source":{"system":"sec-edgar","filing":"0001104659-25-035598","document":"tm2512519-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925035598/tm2512519-1_4seq1.xml","form_type":"4"}},{"id":1211279,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-03-11T23:53:02.000Z","date":"2025-03-11","kind":"sale","planned":false,"acquired":false,"shares":49271,"price":5.01,"value":246847.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 49,271 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 11, 2025, was $4.99 to $5.11. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2003147,"source":{"system":"sec-edgar","filing":"0001104659-25-022655","document":"tm258917-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925022655/tm258917-1_4seq1.xml","form_type":"4"}},{"id":1214357,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-03-10T22:21:57.000Z","date":"2025-03-07","kind":"sale","planned":false,"acquired":false,"shares":14905,"price":5.01,"value":74674.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 14,905 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 7, 2025, was $4.99 to $5.14. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2052418,"source":{"system":"sec-edgar","filing":"0001104659-25-022257","document":"tm258781-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925022257/tm258781-1_4seq1.xml","form_type":"4"}},{"id":1214356,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-03-10T22:21:57.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":25551,"price":5.04,"value":128777.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 25,551 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 6, 2025, was $5.00 to $5.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2067323,"source":{"system":"sec-edgar","filing":"0001104659-25-022257","document":"tm258781-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925022257/tm258781-1_4seq1.xml","form_type":"4"}},{"id":1221288,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-03-06T00:53:31.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":18147,"price":5.13,"value":93094.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 18,147 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 5, 2025, was $5.02 to $5.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2092874,"source":{"system":"sec-edgar","filing":"0001104659-25-021043","document":"tm258375-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925021043/tm258375-1_4seq1.xml","form_type":"4"}},{"id":1221287,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-03-06T00:53:31.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":28901,"price":5.04,"value":145661.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 28,901 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 4, 2025, was $5.00 to $5.17. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2111021,"source":{"system":"sec-edgar","filing":"0001104659-25-021043","document":"tm258375-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925021043/tm258375-1_4seq1.xml","form_type":"4"}},{"id":1221286,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-03-06T00:53:31.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":23508,"price":5.19,"value":122006.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units which vested as of various dates, a total of 23,508 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 3, 2025, was $5.00 to $5.57. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2139922,"source":{"system":"sec-edgar","filing":"0001104659-25-021043","document":"tm258375-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925021043/tm258375-1_4seq1.xml","form_type":"4"}},{"id":1248736,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-02-24T21:01:12.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":1365,"price":5.19,"value":7084.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on February 20, 2025, a total of 1,365 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 21, 2025, was $5.19 to $5.20. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":45966,"source":{"system":"sec-edgar","filing":"0001104659-25-016490","document":"tm257335-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465925016490/tm257335-1_4seq1.xml","form_type":"4"}},{"id":1444047,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-08-01T20:18:22.000Z","date":"2024-08-01","kind":"sale","planned":false,"acquired":false,"shares":9324,"price":5.47,"value":51002.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on July 31, 2024, a total of 9,324 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on August 1, 2024, was $5.45 to $5.55. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods"}],"balance_after":47331,"source":{"system":"sec-edgar","filing":"0001104659-24-084916","document":"tm2420691-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924084916/tm2420691-1_4seq1.xml","form_type":"4"}},{"id":1449876,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35123,"kind":"person","name":"Pearce Michael Cooper","position":1,"cik":"0001413616","reported_name":"Pearce Michael Cooper","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-23T20:01:54.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 19, 2024, the reporting person was granted 30,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest over a three-year period."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-24-081885","document":"tm2420028-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1413616/000110465924081885/tm2420028-2_4seq1.xml","form_type":"4"}},{"id":1449758,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-23T20:01:21.000Z","date":"2024-07-23","kind":"sale","planned":false,"acquired":false,"shares":4055,"price":5.4,"value":21897.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on July 21, 2024, a total of 4,055 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 23, 2024, was $5.40 to $5.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":56655,"source":{"system":"sec-edgar","filing":"0001104659-24-081883","document":"tm2420028-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924081883/tm2420028-1_4seq1.xml","form_type":"4"}},{"id":1457139,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:45:38.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":144445,"source":{"system":"sec-edgar","filing":"0001104659-24-078973","document":"tm2419199-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465924078973/tm2419199-4_4seq1.xml","form_type":"4"}},{"id":1456892,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:45:23.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":81445,"source":{"system":"sec-edgar","filing":"0001104659-24-078972","document":"tm2419199-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924078972/tm2419199-3_4seq1.xml","form_type":"4"}},{"id":1456931,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:45:06.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":81445,"source":{"system":"sec-edgar","filing":"0001104659-24-078970","document":"tm2419199-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465924078970/tm2419199-2_4seq1.xml","form_type":"4"}},{"id":1457110,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:43:34.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":153973,"source":{"system":"sec-edgar","filing":"0001104659-24-078968","document":"tm2419199-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924078968/tm2419199-1_4seq1.xml","form_type":"4"}},{"id":1496608,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc.","position":1,"cik":"0001429260","reported_name":"Fortress Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-05-31T22:26:50.000Z","date":"2023-05-12","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transfer to employees of the Reporting Person as service grants in consideration of services provided to the Reporting Person and to Issuer."}],"balance_after":3860467,"source":{"system":"sec-edgar","filing":"0001104659-24-067324","document":"tm2416203-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924067324/tm2416203-2_4seq1.xml","form_type":"4"}},{"id":1496607,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc.","position":1,"cik":"0001429260","reported_name":"Fortress Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-05-31T22:26:50.000Z","date":"2023-02-12","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transfer to employees of the Reporting Person as service grants in consideration of services provided to the Reporting Person and to Issuer."}],"balance_after":3910467,"source":{"system":"sec-edgar","filing":"0001104659-24-067324","document":"tm2416203-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924067324/tm2416203-2_4seq1.xml","form_type":"4"}},{"id":1496606,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc.","position":1,"cik":"0001429260","reported_name":"Fortress Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-05-31T22:26:50.000Z","date":"2022-11-12","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transfer to employees of the Reporting Person as service grants in consideration of services provided to the Reporting Person and to Issuer."}],"balance_after":3960467,"source":{"system":"sec-edgar","filing":"0001104659-24-067324","document":"tm2416203-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924067324/tm2416203-2_4seq1.xml","form_type":"4"}},{"id":1496605,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc.","position":1,"cik":"0001429260","reported_name":"Fortress Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-05-31T22:26:50.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transfer to employees of the Reporting Person as service grants in consideration of services provided to the Reporting Person and to Issuer."}],"balance_after":4010467,"source":{"system":"sec-edgar","filing":"0001104659-24-067324","document":"tm2416203-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924067324/tm2416203-2_4seq1.xml","form_type":"4"}},{"id":1496604,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc.","position":1,"cik":"0001429260","reported_name":"Fortress Biotech, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-05-31T22:26:50.000Z","date":"2022-05-12","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Transfer to employees of the Reporting Person as service grants in consideration of services provided to the Reporting Person and to Issuer."}],"balance_after":4060467,"source":{"system":"sec-edgar","filing":"0001104659-24-067324","document":"tm2416203-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000110465924067324/tm2416203-2_4seq1.xml","form_type":"4"}},{"id":1559908,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-03-27T11:00:16.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.04,"value":30400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":144245,"source":{"system":"sec-edgar","filing":"0001104659-24-039354","document":"tm249895-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924039354/tm249895-1_4seq1.xml","form_type":"4"}},{"id":1561588,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-03-25T20:03:29.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.479,"value":34790.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 22, 2024, was $3.41 to $3.48. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2163430,"source":{"system":"sec-edgar","filing":"0001104659-24-038437","document":"tm249705-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924038437/tm249705-3_4seq1.xml","form_type":"4"}},{"id":1562566,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-03-25T20:02:02.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.47,"value":104100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":134717,"source":{"system":"sec-edgar","filing":"0001104659-24-038433","document":"tm249705-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465924038433/tm249705-2_4seq1.xml","form_type":"4"}},{"id":1562430,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-03-25T20:01:23.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.4,"value":68000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":134245,"source":{"system":"sec-edgar","filing":"0001104659-24-038431","document":"tm249705-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924038431/tm249705-1_4seq1.xml","form_type":"4"}},{"id":1621621,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-02-23T22:54:53.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":2450,"price":3.75,"value":9187.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on February 20, 2024, a total of 2,768 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 22, 2024, was $3.73 to $3.78. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":60710,"source":{"system":"sec-edgar","filing":"0001104659-24-027147","document":"tm247166-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924027147/tm247166-1_4seq1.xml","form_type":"4"}},{"id":1717438,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-12-08T17:01:18.000Z","date":"2023-11-08","kind":"sale","planned":false,"acquired":false,"shares":255,"price":3.76,"value":958.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of sales of the Issuer's common stock reported herein, as well as the sales reported on a Form 4 filed November 29, 2023, being matched against non-exempt purchases of 4,245 shares of common stock made on September 21, 2023. Accordingly, the reporting person has paid to the Issuer (i) $1,724.98 in connection with the matched sales reported herein and (ii) $4,189.95 in connection with the matched sales made on November 28, 2023, representing the aggregate short-swing profit realized by the reporting person, less transaction costs. Includes 10,000 restricted units of which will vest in full on July 1, 2024 and 27,472 restricted stock units of which will vest on July 21, 2024."}],"balance_after":114217,"source":{"system":"sec-edgar","filing":"0001104659-23-124743","document":"tm2332498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923124743/tm2332498-1_4seq1.xml","form_type":"4"}},{"id":1717437,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-12-08T17:01:18.000Z","date":"2023-11-07","kind":"sale","planned":false,"acquired":false,"shares":2245,"price":3.48,"value":7812.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of sales of the Issuer's common stock reported herein, as well as the sales reported on a Form 4 filed November 29, 2023, being matched against non-exempt purchases of 4,245 shares of common stock made on September 21, 2023. Accordingly, the reporting person has paid to the Issuer (i) $1,724.98 in connection with the matched sales reported herein and (ii) $4,189.95 in connection with the matched sales made on November 28, 2023, representing the aggregate short-swing profit realized by the reporting person, less transaction costs. Includes 10,000 restricted units of which will vest in full on July 1, 2024 and 27,472 restricted stock units of which will vest on July 21, 2024."}],"balance_after":114472,"source":{"system":"sec-edgar","filing":"0001104659-23-124743","document":"tm2332498-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923124743/tm2332498-1_4seq1.xml","form_type":"4"}},{"id":1727435,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-11-29T16:42:16.000Z","date":"2023-11-28","kind":"sale","planned":false,"acquired":false,"shares":1745,"price":5.22,"value":9108.9,"ownership":{"direct":true},"balance_after":70727,"source":{"system":"sec-edgar","filing":"0001104659-23-122072","document":"tm2331786-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923122072/tm2331786-1_4seq1.xml","form_type":"4"}},{"id":1759311,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-10-17T20:01:32.000Z","date":"2023-10-13","kind":"purchase","planned":false,"acquired":true,"shares":33000,"price":2.98,"value":98340.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 13, 2023, was $2.80 to $3.00. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":104717,"source":{"system":"sec-edgar","filing":"0001104659-23-109604","document":"tm2328591-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465923109604/tm2328591-1_4seq1.xml","form_type":"4"}},{"id":1762372,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-10-10T16:41:00.000Z","date":"2023-10-06","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.98,"value":44700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 6, 2023, was $2.97 to $2.99. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":72472,"source":{"system":"sec-edgar","filing":"0001104659-23-108323","document":"tm2328171-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923108323/tm2328171-1_4seq1.xml","form_type":"4"}},{"id":1773770,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-09-25T16:01:37.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.97,"value":89100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 21, 2023, was $2.82 to $3.00. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":57472,"source":{"system":"sec-edgar","filing":"0001104659-23-103509","document":"tm2326865-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923103509/tm2326865-1_4seq1.xml","form_type":"4"}},{"id":1784388,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-09-08T17:26:00.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":26044,"price":2.52,"value":65630.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 6, 2023, was $2.11 to $2.60. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2153430,"source":{"system":"sec-edgar","filing":"0001104659-23-099230","document":"tm2325760-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923099230/tm2325760-2_4seq1.xml","form_type":"4"}},{"id":1785128,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-09-08T17:25:10.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.23,"value":223000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":114245,"source":{"system":"sec-edgar","filing":"0001104659-23-099229","document":"tm2325760-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923099229/tm2325760-1_4seq1.xml","form_type":"4"}},{"id":1823444,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:07:21.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 units of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083836","document":"tm2321950-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465923083836/tm2321950-1_4seq1.xml","form_type":"4"}},{"id":1823753,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:06:31.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 units of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083833","document":"tm2321950-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465923083833/tm2321950-3_4seq1.xml","form_type":"4"}},{"id":1823514,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:06:06.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 units of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083831","document":"tm2321950-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465923083831/tm2321950-4_4seq1.xml","form_type":"4"}},{"id":1823354,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:05:39.000Z","date":"2023-07-24","kind":"sale","planned":false,"acquired":false,"shares":20767,"price":1.76,"value":36549.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on July 24, 2023, a total of 20,767 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 24, 2023, was $1.76 to $1.80. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2127386,"source":{"system":"sec-edgar","filing":"0001104659-23-083828","document":"tm2322027-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923083828/tm2322027-1_4seq1.xml","form_type":"4"}},{"id":1823355,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:05:08.000Z","date":"2023-07-24","kind":"sale","planned":false,"acquired":false,"shares":4072,"price":1.76,"value":7166.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on July 24, 2023, a total of 4,072 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 24, 2023, was $1.76 to $1.80. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":63160,"source":{"system":"sec-edgar","filing":"0001104659-23-083825","document":"tm2322027-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923083825/tm2322027-2_4seq1.xml","form_type":"4"}},{"id":1823402,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T16:06:50.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 units of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 units of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083834","document":"tm2321950-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465923083834/tm2321950-2_4seq1.xml","form_type":"4"}},{"id":1886341,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-05-18T20:31:35.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":24377,"price":1.34,"value":32665.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on May 16, 2023, a total of 44,377 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 17, 2023 was $1.20 to $1.40. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2148153,"source":{"system":"sec-edgar","filing":"0001104659-23-062286","document":"tm2316163-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923062286/tm2316163-1_4seq1.xml","form_type":"4"}},{"id":1886340,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-05-18T20:31:35.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":1.25,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of restricted stock units on May 16, 2023, a total of 44,377 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on May 16, 2023 was $1.25 to $1.27. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":2172530,"source":{"system":"sec-edgar","filing":"0001104659-23-062286","document":"tm2316163-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923062286/tm2316163-1_4seq1.xml","form_type":"4"}},{"id":1982990,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":116225,"kind":"person","name":"De Paolantonio Ernest Robert","position":1,"cik":"0001588538","reported_name":"De Paolantonio Ernest Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-03-01T21:46:27.000Z","date":"2022-10-04","kind":"sale","acquired":false,"shares":10093,"price":2.41,"value":24324.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 40,000 shares on October 1, 2022, a total of 10,093 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 4, 2022, was $2.38 to $2.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Due to a clerical error, the original Form 4 filed on October 6, 2022 reflected an acquisition of 10,029 shares in lieu of a disposition of 10,029 shares. The amount of securities beneficially owned following the reported transaction reported in the previously filed Form 4 is correct."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":259907,"source":{"system":"sec-edgar","filing":"0001104659-23-027555","document":"tm237728-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588538/000110465923027555/tm237728-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-10-06"}},{"id":1995102,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51298,"kind":"person","name":"Benesch Joseph","position":1,"cik":"0001887515","reported_name":"Benesch Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-02-23T22:01:37.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":2768,"price":1.97,"value":5452.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of shares on February 20, 2023, a total of 2,768 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on February 21, 2023, was $1.95 to $1.98. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":67232,"source":{"system":"sec-edgar","filing":"0001104659-23-024810","document":"tm237632-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923024810/tm237632-1_4seq1.xml","form_type":"4"}},{"id":2141052,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":116225,"kind":"person","name":"De Paolantonio Ernest Robert","position":1,"cik":"0001588538","reported_name":"De Paolantonio Ernest Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-10-06T16:30:56.000Z","date":"2022-10-04","kind":"sale","acquired":true,"shares":10093,"price":2.41,"value":24324.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the vesting of 40,000 shares on October 1, 2022, a total of 10,093 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on October 4, 2022, was $2.38 to $2.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":259907,"source":{"system":"sec-edgar","filing":"0001104659-22-106787","document":"tm2227683-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588538/000110465922106787/tm2227683-1_4seq1.xml","form_type":"4"}},{"id":2202933,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:40:22.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,245 restricted stock units, which will vest as set forth in footnote 1."}],"balance_after":14245,"source":{"system":"sec-edgar","filing":"0001104659-22-082291","document":"tm2221508-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922082291/tm2221508-7_4seq1.xml","form_type":"4"}},{"id":2202946,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:39:21.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082290","document":"tm2221508-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465922082290/tm2221508-6_4seq1.xml","form_type":"4"}},{"id":2202752,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:36:51.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest over various time periods as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082288","document":"tm2221508-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465922082288/tm2221508-4_4seq1.xml","form_type":"4"}},{"id":2202814,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:35:20.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082287","document":"tm2221508-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465922082287/tm2221508-3_4seq1.xml","form_type":"4"}},{"id":2202547,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":51296,"kind":"person","name":"Maraoui Claude","position":1,"cik":"0001893880","reported_name":"Maraoui Claude","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:34:01.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 300,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan. One-fourth of the shares will vest on each of July 21, 2023, 2024, 2025 and 2026, subject to the reporting person's continuous service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 742,530 restricted stock units, 300,000 of which will vest over various time periods as set forth in footnote 1, and 442,530 of which will vest in accordance with the following schedule: 147,362 shares on the fifteenth day of the eighteenth month following the closing of the Issuer's initial public offering (the \"Tranche 1 Vesting Date\"); 147,362 of which will vest nine months after the Tranche 1 Vesting Date (the \"Tranche 2 Vesting Date\"), and 147,806 of which will vest nine months after the Tranche 2 Vesting Date."}],"balance_after":2192530,"source":{"system":"sec-edgar","filing":"0001104659-22-082286","document":"tm2221508-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465922082286/tm2221508-2_4seq1.xml","form_type":"4"}},{"id":2202574,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T09:38:30.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082289","document":"tm2221508-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465922082289/tm2221508-5_4seq1.xml","form_type":"4"}},{"id":2202581,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":116225,"kind":"person","name":"De Paolantonio Ernest Robert","position":1,"cik":"0001588538","reported_name":"De Paolantonio Ernest Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T09:32:53.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 150,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan. One-fourth of the shares will vest on each of July 21, 2023, 2024, 2025 and 2026, subject to the reporting person's continuous service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, 150,000 of which will vest over various time periods as set forth in footnote 1, and 120,000 of which will vest in three increments as follows: (1) 40,000 units on October 1, 2022, (2) 40,000 units on October 1, 2023, and (3) 40,000 units on October 1, 2024."}],"balance_after":270000,"source":{"system":"sec-edgar","filing":"0001104659-22-082285","document":"tm2221508-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588538/000110465922082285/tm2221508-1_4seq1.xml","form_type":"4"}},{"id":2307835,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T20:51:39.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042276","document":"tm2211324-8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465922042276/tm2211324-8_4.xml","form_type":"4"}},{"id":2308339,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T20:49:49.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042282","document":"tm2211324-11_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465922042282/tm2211324-11_4.xml","form_type":"4"}},{"id":2309697,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":33368,"kind":"person","name":"Smith Justin Adam","position":1,"cik":"0001894583","reported_name":"Smith Justin Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T20:48:56.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042279","document":"tm2211324-9_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894583/000110465922042279/tm2211324-9_4.xml","form_type":"4"}},{"id":2307180,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":96291,"kind":"person","name":"Paley Jeffrey","position":1,"cik":"0001595327","reported_name":"Paley Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T16:49:21.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042280","document":"tm2211324-10_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595327/000110465922042280/tm2211324-10_4.xml","form_type":"4"}},{"id":2307242,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":116225,"kind":"person","name":"De Paolantonio Ernest Robert","position":1,"cik":"0001588538","reported_name":"De Paolantonio Ernest Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2022-04-04T16:47:41.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 120,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 40,000 units on October 1, 2022, (2) 40,000 units on October 1, 2023, and (3) 40,000 units on October 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":120000,"source":{"system":"sec-edgar","filing":"0001104659-22-042272","document":"tm2211324-7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1588538/000110465922042272/tm2211324-7_4.xml","form_type":"4"}}]}